| Name |
Ranolazin ELC 375 mg tablete s produljenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-439812159 |
| Active Substance |
ranolazin |
| Composition |
jedna tableta sadrži 375 mg ranolazina |
| Pharmaceutical Form |
Tableta s produljenim oslobađanjem |
| Manufacturer |
Adamed Pharma S.A., Pabianice, Poljska |
| Marketing Authorisation Holder |
ELC Group s.r.o., Pobrezni 394/12, Karlin, Prag, Češka |
| Marketing Authorisation Date |
03.06.2022 |
| MA Period of Validity |
03.06.2027 |
| Classification Number |
UP/I-530-09/20-01/302 |
| Registration Number |
381-12-01/38-22-05 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C01EB18 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
